'Our Journey with Lobular Breast Cancer' documentary to premiere at Raindance Film Festival

LONDON - EntSun -- A new documentary highlighting the campaign for research funding into lobular breast cancer will premiere at the 33rd Raindance Film Festival in London this June.

'Our Journey with Lobular Breast Cancer' tells the story of the Lobular Moon Shot Project, launched in 2023 by Dr Susan Michaelis. The campaign has won support from 365 MPs in the House of Commons calling for a five-year, £20 million research programme into invasive lobular breast cancer, the second most common form of breast cancer in the UK.

Invasive lobular breast cancer is difficult to detect with standard mammograms or ultrasounds and currently has no treatment tailored to its unique biology. With an estimated 3.75 million diagnoses worldwide over the next decade, the disease behaves differently from the more common ductal breast cancer and remains an urgent clinical need.

Produced by Fact Not Fiction Films, the documentary will be screened at Vue Piccadilly. The world premiere is scheduled for 5pm on Tuesday 24 June, followed by an additional screening at 12.30pm on Wednesday 25 June. Director Tristan Loraine, nominated for Best Director UK Feature, has two films showing at the festival this year.

More on EntSun News

• Databahn Reveals Smart Sales Agent for Strategic Account Plans
• Editorial Freelancers Association and Thurgood Marshall College Fund Announce Partnership to Advance Editorial Careers for HBCU Students
• ASI Showcasing Constituent Engagement Solutions at ASAE Annual Meeting & Spotlighting iMIS® Partner Marketplace
• LIB's Walk-In Environmental Chambers: Scalable, Specialized, and Built for Industry Extremes
• BetWright Launches Crossbar Challenge Worth Up To £25,000 for Leyton Orient Fans

The Lobular Moon Shot Project aims to raise awareness and secure public funding for a major research initiative led by the Manchester Breast Centre at the University of Manchester. The centre will collaborate with other institutions to deepen global understanding of the disease and develop targeted treatments. Campaigners say the project's estimated £20 million budget over five years is vital to accelerate progress.

• Tickets and more information are available on the Raindance website (https://raindance.eventive.org/films/our-journey-with-lobular-breast-cancer-68270c55c6f850d08af3f136).
• You can access the JustGiving fundraiser (https://www.justgiving.com/page/susan-michaelis-lobular-research-manchester-breast-centre?utm_medium=fundraising&utm_content=page%2Fsusan-michaelis-lobular-research-manchester-breast-centre&utm_source=copyLink&utm_campaign=pfp-share) to make a donation.

About The Lobular Moon Shot Project

More on EntSun News

• Vitanergy Health US Inc. Launches Three New Women's Supplements in the US: Vegan, Clean-Label, and Made in the USA
• Boingo Emerges as the #1 Platform for Finding Real Estate in Mexico — Outpacing Traditional Portals
• Members Only & Lance Romance Announce $230M Music-Fashion Partnership with Charitable Impact
• Karapancev Law Welcomes New Associate Lawyers as Firm Expands Capacity
• T3 Event Rentals Expands Inventory With Lounge Furniture After Being Named a 2025 Market Mover

The Lobular Moon Shot Project was established in 2023 to address a critical gap in breast cancer research. Its mission is to secure funding for vital studies that will improve understanding of invasive lobular breast cancer (ILC) and support the development of targeted treatments. Alongside fundraising efforts, the project works to build political support to ensure governments provide dedicated funding for research into this disease.

Although some research is currently underway worldwide, a coordinated large-scale study is urgently needed. The project calls for a £20 million investment over five years to accelerate progress.

About Fact Not Fiction Films

Fact Not Fiction Films, founded in 2006 and based in West Sussex, England, is an award-winning production company specialising in documentaries, feature films, and corporate videos. The company focuses on stories that explore important public issues, combining creative passion with technical expertise and high-quality production standards. Its work is suitable for corporate clients, broadcast audiences, and theatrical releases.